Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.

Biotechnology

Health Care

Health Diagnostics

Orionis Biosciences

Nikolai Kley

Riccardo Sabatini

Robert Petit

James Kyranos

Azza A. Gadir, PhD

Andrew Littlehale

The Research and Development Team at Orionis Biosciences is dedicated to pioneering innovative therapies in oncology and immunotherapy. This multidisciplinary group of scientists and specialists focuses on drug discovery and development by leveraging advanced technologies, conducting rigorous experimental research, and analyzing complex data to identify and validate new therapeutic targets. Their collaborative efforts aim to address significant gaps in the treatment of diseases with high unmet medical needs, driving forward the company's mission to deliver transformative medicines.

Research and Development Team

Leadership Team

Operations Team

Research and Development Team

About

Team members

Other teams at Orionis Biosciences

Leadership Team

Operations Team